- Home
- EXEL vs NVT Comparison
EXEL vs NVT Comparison
Compare EXEL & NVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- NVT
- Stock Information
- Founded
- EXEL 1994
- NVT 1903
- Country
- EXEL United States
- NVT United Kingdom
- Employees
- EXEL N/A
- NVT N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- NVT Industrial Machinery/Components
- Sector
- EXEL Health Care
- NVT Industrials
- Exchange
- EXEL Nasdaq
- NVT Nasdaq
- Market Cap
- EXEL 10.0B
- NVT 12.0B
- IPO Year
- EXEL 2000
- NVT N/A
- Fundamental
- Price
- EXEL $34.59
- NVT $73.01
- Analyst Decision
- EXEL Buy
- NVT Strong Buy
- Analyst Count
- EXEL 17
- NVT 6
- Target Price
- EXEL $32.18
- NVT $85.50
- AVG Volume (30 Days)
- EXEL 1.7M
- NVT 1.3M
- Earning Date
- EXEL 02-04-2025
- NVT 02-04-2025
- Dividend Yield
- EXEL N/A
- NVT 1.05%
- EPS Growth
- EXEL 441.02
- NVT 21.96
- EPS
- EXEL 1.55
- NVT 3.42
- Revenue
- EXEL $2,081,598,000.00
- NVT $3,539,100,000.00
- Revenue This Year
- EXEL $20.59
- NVT N/A
- Revenue Next Year
- EXEL $1.50
- NVT $5.18
- P/E Ratio
- EXEL $22.41
- NVT $21.23
- Revenue Growth
- EXEL 17.31
- NVT 30.11
- 52 Week Low
- EXEL $19.20
- NVT $55.19
- 52 Week High
- EXEL $36.97
- NVT $86.57
- Technical
- Relative Strength Index (RSI)
- EXEL 51.61
- NVT 40.62
- Support Level
- EXEL $34.30
- NVT $71.92
- Resistance Level
- EXEL $36.22
- NVT $76.48
- Average True Range (ATR)
- EXEL 0.75
- NVT 1.93
- MACD
- EXEL -0.29
- NVT -0.62
- Stochastic Oscillator
- EXEL 25.09
- NVT 7.38
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About NVT nVent Electric plc
nVent is a leading global provider of electrical connection and protection solutions that touches a broad range of end markets including infrastructure, industrial, commercial, and residential. NVent designs, manufacturers, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. nVent currently has three reportable segments: Enclosures, Electrical & Fastening Solutions, and Thermal Management. Thermal Management is expected to be sold by early 2025. North America accounts for the majority of sales.